A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
Clinical trial NCT03235986 · TERMINATED
Trial details
- NCT number
- NCT03235986
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2020-05-05
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.